Anlon Healthcare Limited IPO Review
Neutral86-91 · Mainboard
✦
Analyst Verdict
Anlon Healthcare Limited IPO
Neutral
IPO at a Glance
Price Band
86-91
Issue Size
121cr
Min. Investment
₹14,924
Opens
2025-08-24
Closes
2025-08-27
Listing
2025-09-01
Category
Mainboard
Key Strengths
✓Diverse product portfolio with scalable business operations.
✓Experienced promoters and a competent management team.
✓High entry barriers due to strict approval standards.
✓In-house testing ensures consistent quality and compliance.
✓Emphasis on Quality, Environment, Health, and Safety (QEHS).
Key Risks
⚠High dependency on a single manufacturing unit in Rajkot, Gujarat.
⚠Revenue concentration from the top few pharmaceutical industry customers.
⚠Limited experience in complex pharma intermediates manufacturing.
⚠Heavy reliance on select suppliers from western India.
⚠Delay in regulatory approvals can halt operations and revenue.
Frequently Asked Questions
Should I apply for Anlon Healthcare Limited IPO?
Based on our analysis, our rating for Anlon Healthcare Limited IPO is: Neutral. Review the full analysis including strengths, risks, and financials on CheckIPO before making a decision.
What are the key risks of Anlon Healthcare Limited IPO?
High dependency on a single manufacturing unit in Rajkot, Gujarat. Revenue concentration from the top few pharmaceutical industry customers. Limited experience in complex pharma intermediates manufacturing.
What are the strengths of Anlon Healthcare Limited IPO?
Diverse product portfolio with scalable business operations. Experienced promoters and a competent management team. High entry barriers due to strict approval standards.
What is the price band of Anlon Healthcare Limited IPO?
The price band for Anlon Healthcare Limited IPO is 86-91. The IPO has closed.
Full Analysis Available
Financials, DRHP breakdown, peer comparison, shareholding pattern & more